Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Kuehl, P. M., Zhang, J., Lin, Y., Lamba, J. K., Assem, M., Schuetz, J. D., Watkins, P. B., Daly, A. K., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,172

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

Ekberg, H., Junior, H. T. S., Demirbas, A., Vitko, S., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyo, J. M., Frei, U. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,814

Genetic contribution to variable human CYP3A-mediated metabolism

Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 987

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Vincenti, F. G., Charpentier, B., Vanrenterghem, Y. F. C., Rostaing, L. P. E., Bresnahan, B. A., Darji, P., Massari, P. U., Mondragón-Ramírez, G., Agarwal, M., Russo, G. D., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03005.x · Cited by 958

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Lamb, K. E., Lodhi, S. A., & Meier-Kriesche, H.-U. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03283.x · Cited by 934

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

Fruman, D. A., Klee, C. B., Bierer, B. E., & Burakoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3686 · Cited by 823

Belatacept and Long-Term Outcomes in Kidney Transplantation

Vincenti, F. G., Rostaing, L. P. E., Grinyo, J. M. B., Rice, K. M., Steinberg, S., Gaite, L., Moal, M., Mondragón-Ramírez, G., Kothari, J., Polinsky, M. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506027 · Cited by 789

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Birdwell, K. A., Decker, B. S., Barbarino, J. M., Peterson, J., Stein, C., Sadée, W., Wang, D., Vinks, A. A. T. M. M., He, Y., Swen, J. J., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.113 · Cited by 751

The genetic determinants of the CYP3A5 polymorphism

Hustert, E., Haberl, M., Burk, O., Wolbold, R., He, Y.-Q., Klein, K., Nussler, A. K., Neuhaus, P., Klattig, J., Eiselt, R., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00005 · Cited by 673

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

Straßl, R. P., Schiemann, M., Doberer, K., Görzer, I., Puchhammer‐Stöckl, E., Eskandary, F. A., Kikić, Ž., Gualdoni, G. A., Vossen, M. G., Rasoul‐Rockenschaub, S., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy306 · Cited by 139

Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial

Doberer, K., Schiemann, M., Straßl, R. P., Haupenthal, F., Dermuth, F., Görzer, I., Eskandary, F. A., Reindl‐Schwaighofer, R., Kikić, Ž., Puchhammer‐Stöckl, E., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15810 · Cited by 132

Tacrolimus Exposure Prediction Using Machine Learning

Woillard, J., Labriffe, M., Debord, J., & Marquet, P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2123 · Cited by 112

Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome

Schijvens, A. M., ter Heine, R., de Wildt, S. N., & Schreuder, M. F. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3929-z · Cited by 89

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients

Straßl, R. P., Doberer, K., Rasoul‐Rockenschaub, S., Herkner, H., Görzer, I., Kläger, J. P., Schmidt, R. L. J., Haslacher, H., Schiemann, M., Eskandary, F. A., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz039 · Cited by 79

Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression

Jaksch, P., Görzer, I., Puchhammer‐Stöckl, E., & Bond, G. (2022) · Transplantation · doi:10.1097/tp.0000000000004153 · Cited by 79

Immunosuppressive Drugs

Hussain, Y., & Khan, H. Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00068-9 · Cited by 90

Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable

Dai, C., Walker, J. T., Shostak, A., Padgett, A., Spears, E., Wisniewski, S., Poffenberger, G., Aramandla, R., Dean, E. D., Prasad, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.130770 · Cited by 64

Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial

Doberer, K., Haupenthal, F., Nackenhorst, M. C., Bauernfeind, F., Dermuth, F., Eigenschink, M., Schiemann, M., Kläger, J. P., Görzer, I., Eskandary, F. A., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003619 · Cited by 62

Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation

Tron, C., Lemaitre, F., Verstuyft, C., Petitcollin, A., Verdier, M., & Bellissant, É. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0717-7 · Cited by 61

Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs

Taddeo, A., Prim, D., Bojescu, E.-D., Segura, J., & Pfeifer, M. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa067 · Cited by 51

Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review

Le, H. L., Francke, M. I., Andrews, L. M., de Winter, B. C. M., van Gelder, T., & Hesselink, D. A. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000769 · Cited by 47

Effect of a Smart Pill Bottle and Pharmacist Intervention on Medication Adherence in Patients with Multiple Myeloma New to Lenalidomide Therapy

Mauro, J., Mathews, K., & Sredzinski, E. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.11.1244 · Cited by 42

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients

Thongprayoon, C., Hansrivijit, P., Kovvuru, K. R., Kanduri, S. R., Bathini, T. J., Pivovarova, A. I., Smith, J. R., & Cheungpasitporn, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072193 · Cited by 41

Exploring the neuroregenerative potential of tacrolimus

Saffari, T. M., Bedar, M., Zuidam, J. M., Shin, A. Y., Baan, C. C., Hesselink, D. A., & Hundepool, C. A. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1675507 · Cited by 41

Immunosuppression-related neurological disorders in kidney transplantation

Faravelli, I., Velardo, D., Podestà, M. A., & Ponticelli, C. (2021) · Journal of Nephrology · doi:10.1007/s40620-020-00956-1 · Cited by 44

Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives

Oberbauer, R. W., Bestard, O., Furian, L., Maggiore, U., Pascual, J., Rostaing, L. P. E., & Budde, K. (2020) · Transplantation Reviews · doi:10.1016/j.trre.2020.100531 · Cited by 38

Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence

Zheng, P., Yu, Z. Y., Li, L., Liu, S., Lou, Y., Hao, X., Peng, Y., Lei, M., Qi, Q., Wang, Z., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.727245 · Cited by 37

Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling

Gustavsen, M. T., Midtvedt, K., Vethe, N. T., Robertsen, I., Bergan, S., & Åsberg, A. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000697 · Cited by 35

Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices

Seyfinejad, B., & Jouyban, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114315 · Cited by 35

Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients

Rojas, A. M., Hesselink, D. A., van Besouw, N. M., Baan, C. C., & van Gelder, T. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1693263 · Cited by 32

Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial

Fleming, J. N., Gebregziabher, M., Posadas, M. A., Su, Z., McGillicuddy, J. W., & Taber, D. J. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab157 · Cited by 31

The gut microbiome in solid organ transplantation

Arassi, M. B., Zeller, G., Karcher, N., Zimmermann, M., & Tönshoff, B. (2020) · Pediatric Transplantation · doi:10.1111/petr.13866 · Cited by 27

Individualized dosing algorithms for tacrolimus in kidney transplant recipients: current status and unmet needs

Schagen, M. R., Volarević, H., Francke, M. I., Sassen, S. D. T., Reinders, M. E. J., Hesselink, D. A., & de Winter, B. C. M. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2250251 · Cited by 29

Nanosensors for Therapeutic Drug Monitoring: Implications for Transplantation

Shafiee, A., Ghadiri, E., Kassis, J. N., & Atala, A. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0150 · Cited by 25

Effect of ABCB1 3435C>T Genetic Polymorphism on Pharmacokinetic Variables of Tacrolimus in Adult Renal Transplant Recipients: A Systematic Review and Meta-analysis

Peng, W., Yang, L., Zhang, H., & Meng, K. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.016 · Cited by 23

Torque‐teno virus for the prediction of graft rejection and infection disease after kidney transplantation: A systematic review and meta‐analysis

Zeng, J., Tang, Y., Lin, T., & Song, T. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28677 · Cited by 22

Kinetics of Torque Teno Virus Viral Load Is Associated with Infection and De Novo Donor Specific Antibodies in the First Year after Kidney Transplantation: A Prospective Cohort Study

Querido, S., Martins, C. G., Gómes, P., Pessanha, M. A., Arroz, M. J., Adragão, T., Casqueiro, A., Oliveira, R., Costa, I., Azinheira, J., et al. (2023) · Viruses · doi:10.3390/v15071464 · Cited by 21

Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients

Rong, Y., Mayo, P., Ensom, M. H. H., & Kiang, T. K. L. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0525-3 · Cited by 20

Immunosuppressive therapy post-transplantation in children: what the clinician needs to know

Tönshoff, B. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1714437 · Cited by 20

Emerging Roles for Lymphatics in Chronic Liver Disease

Burchill, M. A., Goldberg, A. R., & Tamburini, B. A. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01579 · Cited by 18

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

Veld, A. E. I. ‘., Grievink, H. W., Saghari, M., Stuurman, F. E., de Kam, M. L., de Vries, A. P. J., de Winter, B. C. M., Burggraaf, J., Cohen, A. F., & Moerland, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194710 · Cited by 17

Prolongation of graft survival via layer-by-layer assembly of collagen and immunosuppressive particles on pancreatic islets

Tran, P. L., Kim, J., Jung, Y., Lee, D.-C., Choi, J. U., Le, D. N., Nam, J., Shrestha, M., Kim, J.-Y., Pham, T. T., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121804 · Cited by 16

Predictive engines based on pharmacokinetics modelling for tacrolimus personalized dosage in paediatric renal transplant patients

Prado-Velasco, M., Borobia, A. M., & Carcas, A. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64189-9 · Cited by 16

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation

Kim, H. K., Han, A., Ahn, S., Min, S., Ha, J., & Min, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-43755-x · Cited by 15

P-glycoprotein, FK-binding Protein-12, and the Intracellular Tacrolimus Concentration in T-lymphocytes and Monocytes of Kidney Transplant Recipients

Udomkarnjananun, S., Francke, M. I., Dieterich, M., van de Velde, D., Litjens, N. H. R., Boer, K., de Winter, B. C. M., Baan, C. C., & Hesselink, D. A. (2022) · Transplantation · doi:10.1097/tp.0000000000004287 · Cited by 14

Calcineurin inhibitors in lupus nephritis

Ponticelli, C. E., & Podestà, M. A. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00757-6 · Cited by 14

Dynamics of torque teno virus load in kidney transplant recipients with indication biopsy and therapeutic modifications of immunosuppression

Reineke, M., Morath, C. P., Speer, C., Rudek, M. A., Bundschuh, C., Klein, J. A. F., Mahler, C. F., Kälble, F., Nußhag, C., Beimler, J., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1337367 · Cited by 13

Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels

Guo, H., Xu, J., Sun, J., Li, L., Guo, H.-L., Xia, J., Xu, Z.-Y., Hu, Y., Xu, Z., Sun, F., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106290 · Cited by 13

Tacrolimus Exposure in Obese Patients: and A Case–Control Study in Kidney Transplantation

Robert, V., Sampol-Manos, E., Manson, T., Robert, T., Decourchelle, N., Gruliere, A.-S., Quaranta, S., Moal, V., & Legris, T. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000820 · Cited by 13

Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients

Fontova, P., Colom, H., Rigo-Bonnin, R. F., Bestard, O., Vidal‐Alabró, A., van Merendonk, L. N., Cerezo, G., Polo, C., Montero, N., Melilli, E., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2220 · Cited by 13

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients

Kannegieter, N. M., Hesselink, D. A., Dieterich, M., de Graav, G. N., Kraaijeveld, R., & Baan, C. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201113 · Cited by 13

Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients

Cheng, S., Tang, M., Du, J., & Yin, T. (2020) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2020-002385 · Cited by 15

Prospective cohort study of Torque Teno Virus (TTV) viral load kinetics and the association with graft rejection in renal transplant patients

Reyes, N. S., Laham, G., Boccia, N., García, G., Jara, R., Hermida, E., Ricarte, C., Diaz, C. H., Pujol, G. S., Poletta, F. A., et al. (2023) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105501 · Cited by 12

Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework

Centanni, M., Reijnhout, N. D., Thijs, A., Karlsson, M. O., & Friberg, L. E. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01382-3 · Cited by 12

Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients

Lago, S. D., Brani, P., Ietto, G., Gasperina, D. D., Gianfagna, F., Giaroni, C., Bosi, A., Ferrante, F. D., Genoni, A. P., Manzoor, H. Z., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147744 · Cited by 12

Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series

Ambarsari, C. G., Hidayati, E. L., Hasan, I., Grace, A., & Oswari, H. (2020) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s248632 · Cited by 12

Physiologically-based pharmacokinetic modeling-guided rational combination of tacrolimus and voriconazole in patients with different CYP3A5 and CYP2C19 alleles

Gong, F., Hu, H., Ouyang, Y., Liao, Z., Kong, Y., Hu, J., He, H., & Zhou, Y. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116475 · Cited by 12

Machine Learning Models for Predicting Personalized Tacrolimus Stable Dosages in Pediatric Renal Transplant Patients

Sánchez-Herrero, S., Calvet, L., & Juan, A. A. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3040057 · Cited by 11

Optimum tacrolimus trough levels for enhanced graft survival and safety in kidney transplantation: a retrospective multicenter real-world evidence study

Han, A., Jo, A. J., Kwon, H., Kim, Y. H., Lee, J., Huh, K. H., Lee, K. W., Park, J. B., Jang, E., Park, S. C., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001800 · Cited by 11

The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial

Susomboon, T., Kunlamas, Y., Vadcharavivad, S., & Vongwiwatana, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18552-7 · Cited by 11

Smoking, Alcohol Intake and Torque Teno Virus in Stable Kidney Transplant Recipients

Doorenbos, C. S. E., Jonker, J., Hao, J., Gore, E. J., Kremer, D., Knobbe, T. J., de Joode, A. A. E., Sanders, J., Thaunat, O., Niesters, H. G. M., et al. (2023) · Viruses · doi:10.3390/v15122387 · Cited by 11

De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial

Zyl, J. S. V., Sam, T., Clark, D. M., Felius, J., Doss, A. K., Kerlee, K. R., Cheung, Z.-O., Martits‐Chalangari, K., Jamil, A. K., Carey, S. A., et al. (2021) · Clinical Transplantation · doi:10.1111/ctr.14487 · Cited by 11

The Influence of Tacrolimus Exposure and Metabolism on the Outcomes of Kidney Transplants

Maslauskienė, R., Vaičiūnienė, R., Radzevičienė, A., Tretjakovs, P., Gersone, G., Stankevıčıus, E., & Bumblytė, I. A. (2024) · Biomedicines · doi:10.3390/biomedicines12051125 · Cited by 10

Establishment of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Immunosuppressant Levels in the Peripheral Blood Mononuclear Cells of Chinese Renal Transplant Recipients

Chen, B. Y., Lu, J., Shao, K., Zhai, X.-H., An, H., Shi, H., & Zhou, P. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000765 · Cited by 10

Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient

Meaney, C. J., O’Connor, M., McGowan, M., Hamid, M., & Su, W. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12829 · Cited by 10

Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Wang, Z., Zheng, M., Yang, H., Han, Z., Tao, J., Chen, H., Sun, L. Y., Guo, M., Wang, L., Tan, R., et al. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190627101927 · Cited by 10

Analysis of Immunosuppressant Drugs in Whole Blood by Liquid Chromatography–Tandem Mass Spectrometry (LC‐MS/MS)

Pablo, A., Breaud, A. R., & Clarke, W. A. (2020) · Current Protocols in Toxicology · doi:10.1002/cptx.92 · Cited by 10

The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients

Wang, X., Shao, K., An, H., Zhai, X.-H., Zhou, P., & Chen, B. Y. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03215-9 · Cited by 9

Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism

Liu, F., Aulin, L. B. S., Manson, M. L., Krekels, E. H. J., & van Hasselt, J. G. C. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00852-6 · Cited by 9

Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients

Kim, J. M., Ryu, J. H., Lee, K., Hong, S. K., Yang, K., Choi, G., Kim, Y. A., Lee, J., Yi, N., Kwon, C. H. D., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092897 · Cited by 9

Unraveling the Genomic Architecture of the CYP3A Locus and ADME Genes for Personalized Tacrolimus Dosing

Yoon, J. G., Song, S. H., Choi, S., Oh, J., Jang, I., Kim, Y. J., Moon, S., Kim, B.-J., Cho, Y., Kim, H. K., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003660 · Cited by 9

Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end‐stage renal disease

Tanaka, R., Suzuki, Y., Watanabe, H., Fujioka, T., Hirata, K., Shin, T., Ando, T., Ono, H., Tatsuta, R., Mimata, H., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.13065 · Cited by 9

Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations

Sajjadi, S., Shayanfar, A., Kiafar, F., & Siahi‐Shadbad, M. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100285 · Cited by 8

A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study

Lhermitte, R., Daré, B. L., Laval, F., Lemaitre, F., Troussier, B., Morin, M.-P., Vigneau, C. M., Chemouny, J., & Bacle, A. (2023) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2022-003625 · Cited by 8

Bayesian optimization of tacrolimus exposure in stable kidney transplant patients

Nguyen, T. D., Smith, N. M., Attwood, K. M., Gundroo, A. A., Chang, S. S., Yonis, M., Murray, B. M., & Tornatore, K. M. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2848 · Cited by 8

Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients

Gallant, J., Wichart, J., & Kiang, T. K. L. (2019) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-019-00553-z · Cited by 8

Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS

van Merendonk, L. N., Fontova, P., Rigo-Bonnin, R. F., Colom, H., Vidal‐Alabró, A., Bestard, O., Torrás, J., Cruzado, J. M., Grinyo, J. M., & Lloberas, N. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.033 · Cited by 8

Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring)

Fontova, P., Rigo-Bonnin, R. F., Vidal‐Alabró, A., Cerezo, G., Bestard, O., Cruzado, J. M., Torrás, J., Grinyo, J. M., & Lloberas, N. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.04.079 · Cited by 8

Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule

Hirata, K., Watanabe, H., Toyoda, M., Sugimoto, R., Ikegami, K., Imafuku, T., Matsuzaka, K., Ichimizu, S., Maeda, H., Uekihara, S., et al. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00976 · Cited by 8

Donor CYP3A5 Gene Polymorphism Alone Cannot Predict Tacrolimus Intrarenal Concentration in Renal Transplant Recipients

Zhang, M., Tajima, S., Shigematsu, T., Fu, R., Noguchi, H., Kaku, K., Tsuchimoto, A., Okabe, Y., Egashira, N., & Masuda, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082976 · Cited by 8

Torque Teno Virus as a Biomarker for Infection Risk in Kidney Transplant Recipients: A Machine Learning-Enabled Cohort Study

Querido, S., Ramalhete, L., Gómes, P., & Weigert, A. L. L. (2025) · Infectious Disease Reports · doi:10.3390/idr17050107 · Cited by 7

Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients

Largeau, B., Guellec, C. B., Longuet, H., Lesne, P., Bouvarel, A., Préteseille, L., Marquet, P., Halimi, J., Büchler, M., Gatault, P., et al. (2019) · Progress in Transplantation · doi:10.1177/1526924819873905 · Cited by 7

Population PK / PD model of tacrolimus for exploring the relationship between accumulated exposure and quantitative scores in myasthenia gravis patients

Chen, D., Yao, Q., Chen, W., Yin, J., Hou, S., Tian, X., Zhao, M., Zhang, H., Yang, L., Zhou, T., et al. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12966 · Cited by 7

Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy

Bonezi, V., Genvigir, F. D. V., Salgado, P. D. C., Felipe, C. R., Junior, H. T. S., Medina-Pestana, J. O., Cerda, Á., Doi, S. Q., Hirata, M. H., & Hirata, R. D. C. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1757 · Cited by 7

Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules

Bi, F., Yuan, T., Zhang, B., Li, J., Yan, L., & Yang, J. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-03006-2 · Cited by 6

Prediction of the Intra‐T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling

Udomkarnjananun, S., Schagen, M. R., Volarević, H., van de Velde, D., Dieterich, M., Matić, M., Baan, C. C., Reinders, M. E. J., de Winter, B. C. M., & Hesselink, D. A. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3419 · Cited by 6

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

Fontova, P., van Merendonk, L. N., Vidal‐Alabró, A., Rigo-Bonnin, R. F., Cerezo, G., van Oevelen, S., Bestard, O., Melilli, E., Montero, N., Coloma, A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051481 · Cited by 6

Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressantsPreprint

Arassi, M. B., Karcher, N., Mastrorilli, E., Groß, M., Brauer-Nikonow, A., Hackett, R., Czock, D., Tönshoff, B., Zeller, G., & Zimmermann, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.28.586928 · Cited by 6

Interactions of TTV with BKV, CMV, EBV, and HHV-6A and their impact on post-transplant graft function in kidney transplant recipients

Rosiewicz, K. S., Blazquez‐Navarro, A., Kaliszczyk, S., Bauer, C., Or‐Guil, M., Viebahn, R., Zgoura, P., Reinke, P., Roch, T., Hugo, C., et al. (2024) · Frontiers in Transplantation · doi:10.3389/frtra.2024.1393838 · Cited by 5

Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report

Onodera, R., Nihei, S., Kimura, T., Tomita, T., & Kudo, K. (2020) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-020-00175-7 · Cited by 5

Towards Next-Generation Personalization of Tacrolimus Treatment: a Review on Advanced Diagnostic and Therapeutic Approaches

Radhakrishnan, A., Kuppusamy, G., Ponnusankar, S., & Mutalik, S. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0008 · Cited by 5

Individualized Dosage of Tacrolimus for Renal Transplantation Patients Based on Pharmacometabonomics

He, X., Yang, X., Yan, X., Huang, M., Xiang, Z., & Lou, Y. (2022) · Molecules · doi:10.3390/molecules27113517 · Cited by 5

Determining Plasma Tacrolimus Concentrations Using High-Performance LC-MS/MS in Renal Transplant Recipients

Alonge, M., Coller, J. K., Reuter, S. E., Jesudason, S., & Sallustio, B. C. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001135 · Cited by 4

INSIGHT INTO THE POTENTIAL INFLUENCE OF INTER- AND INTRA-INDIVIDUAL VARIABILITY OF TACROLIMUS EXPOSURE ON GRAFT FUNCTION DECLINE IN THREE-YEAR PERIOD FOLLOWING KIDNEY TRANSPLANTATION

STEFANOVIĆ, N. Z. (2020) · FARMACIA · doi:10.31925/farmacia.2020.6.10 · Cited by 4

The CYP3A5 and ABCB1 Gene Polymorphisms in Kidney Transplant Patients and Establishment of Initial Daily Tacrolimus Dosing Formula

He, Y., Ma, Y., Fu, Q., Liang, J., Yu, X., Huang, H., Zhong, L., & Huang, B. (2021) · Annals of Pharmacotherapy · doi:10.1177/10600280211023495 · Cited by 4

Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices

Basu, B., Prajapati, B. G., Mukherjee, S., Roy, T. K., Roy, A., Hossain, C. M., Prajapati, J. B., & Patel, J. K. (2022) · Springer eBooks · doi:10.1007/978-3-031-12398-6_7 · Cited by 4

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation

Yin, J. H., Hsu, T., Kerr, J., Steiner, R. W., & Awdishu, L. (2020) · Pharmacy · doi:10.3390/pharmacy8020060 · Cited by 4

Evaluation of Effective Half-Life and Its Impact on Time to Steady State for Oral MeltDose Tacrolimus (LCPT) in De Novo Kidney Transplant Recipients

Momper, J. D., Venkataramanan, R., Jantz, A. S., Cibrik, D. M., Birdwell, K., Nguyen, T., Masters, B. M., & Patel, S. J. (2025) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001270 · Cited by 3

Renal Transplantation: Immunosuppression and Managing Allograft Rejection

Tönshoff, B., Sarwal, M., Marks, S. D., & Moudgil, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_136 · Cited by 3

Tacrolimus’s Time Below Therapeutic Range Is Associated With Acute Pancreatic Graft Rejection and the Development of De Novo Donor-specific Antibodies

Rodríguez‐Espinosa, D., Broseta, J. J., Montagud‐Marrahí, E., Arana, C., Ferrer, J., Cuatrecasas, M., García‐Criado, Á., Amor, A. J., Diekmann, F., & Ventura‐Aguiar, P. (2024) · Transplant International · doi:10.3389/ti.2024.12591 · Cited by 3

Development and Validation of A Liquid Chromatography–Tandem Mass Spectrometry Method to Simultaneously Measure Tacrolimus and Everolimus Concentrations in Kidney Allograft Biopsies After Kidney Transplantation

Zhang, M., Tajima, S., Shigematsu, T., Noguchi, H., Kaku, K., Tsuchimoto, A., Okabe, Y., Egashira, N., & Ieiri, I. (2021) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000912 · Cited by 3

Conversion from Twice-Daily Prograf® to Once-Daily Advagraf® in Multi-ethnic Asian Adult Renal Transplant Recipients With or Without Concomitant Use of Diltiazem: Impact of CYP3A5 and MDR1 Genetic Polymorphisms on Tacrolimus Exposure

Yau, W., Loh, C. W.-T., & Vathsala, A. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0531-5 · Cited by 3

Concentration-dependent blood binding: assessing implications through physiologically based Pharmacokinetic modeling of tacrolimus as a case example

El‐Khateeb, E., Karsanji, D., Darwich, A. S., & Rostami‐Hodjegan, A. (2025) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-025-09992-5 · Cited by 2

New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation

Rațiu, I. A., Bănică, F., Moisa, C., Pașca, B., Gîtea, D., Grosu, I. D., Bako, G. C., Voștinaru, O., Dayyih, W. A., & Filip, L. A. (2025) · Pharmaceuticals · doi:10.3390/ph18101532 · Cited by 2

Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection

Leino, A. D., & Pai, M. P. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00923-w · Cited by 2

Exploring the Association Between Torquetenovirus Viral Load and Immunosuppressive Drug Exposure in Lung Transplantation

Cuesta, V. M. M., Rodrigo, E., Fernandez, D. I., Izquierdo, S., Tello, S., Benito‐Hernández, A., García-Saiz, M. D. M., Segundo, D. S., Francia, M. V., & Martínez, J. M. C. (2025) · Biomolecules · doi:10.3390/biom15040494 · Cited by 2

Exploring Net Immunosuppressive Status with Torque Teno Virus Viral Load in Kidney Transplant Recipients with High Molecular Injury

Rodrigo, E., González-López, E., Ocejo-Vinyals, J. G., Pasache, J. E., García-Majado, C., del Moral, C. L., Santiago, A. G., Benito‐Hernández, A., Francia, M. V., & Ruiz, J. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072417 · Cited by 2

The Future of Paediatric Nephrology—Genomics and Personalised Precision Medicine

Quinlan, C. (2020) · Current Pediatrics Reports · doi:10.1007/s40124-020-00218-5

Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant

Lin, Y., Li, Y., Li, Y., Bai, Y., Wan, Z., Fan, J.-W., Luo, L., Wang, L., & Shi, Y. (2021) · Medicine · doi:10.1097/md.0000000000024762 · Cited by 2

Progress in tacrolimus monitoring in organ transplantation : a multidisciplinary approach

Capron, A. (2010) · Digital Access to Libraries

Dosing Tacrolimus Based on CYP3A5 Genotype: Will It Improve Clinical Outcome?

van Gelder, T., & Hesselink, D. A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.42 · Cited by 38

Monitoring Intra-cellular Tacrolimus Concentrations in Solid Organ Transplantation: Use of Peripheral Blood Mononuclear Cells and Graft Biopsy Tissue

Sallustio, B. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.733285 · Cited by 25

Tacrolimus—why pharmacokinetics matter in the clinic

Henkel, L., Jehn, U., Thölking, G., & Reuter, S. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1160752 · Cited by 40

Therapeutic drug monitoring of tacrolimus in kidney transplantation

Bansal, S. (2020) · Indian Journal of Transplantation · doi:10.4103/ijot.ijot_4_20 · Cited by 7